SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-149484
Filing Date
2013-04-10
Accepted
2013-04-10 17:27:55
Documents
4
Period of Report
2013-04-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d518872d8k.htm 8-K 21578
2 EX-5.1 d518872dex51.htm EX-5.1 9340
3 EX-10.1 d518872dex101.htm EX-10.1 12014
4 GRAPHIC g518872g24v79.jpg GRAPHIC 7046
  Complete submission text file 0001193125-13-149484.txt   54063
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 13754491
SIC: 2834 Pharmaceutical Preparations